Liddle Syndrome Presenting as Hypertensive Crisis and Myocardial Injury in a Young Male: A Case Report
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Nephrology
- Vol. 2026 (1) , 7218869
Abstract
Introduction: Liddle’s syndrome is a rare inherited disorder associated with early‐onset and resistant hypertension due to hyperactivity of epithelial sodium channels (ENaCs). The condition is caused by mutations in the genes SCNN1A, SCNN1B, and SCNN1G. Liddle’s syndrome leads to hypertension, hypokalemia, and metabolic alkalosis. Case Presentation: A previously healthy 21‐year‐old male patient complained of severe central chest pain radiating to both arms and had a hypertensive emergency with a BP reading of 267/170 mmHg. The patient had marked elevation in troponin I (13.9 ng/mL), hypokalemia (2.8 mmol/L), and metabolic alkalosis. The electrocardiogram showed left ventricular hypertrophy with a strain pattern and QTc prolongation due to hypokalemia. Coronary angiography ruled out the possibility of primary acute coronary syndrome by revealing normal coronary arteries. Echocardiogram showed concentric left ventricular hypertrophy with normal ejection fraction and no wall motion abnormalities. In search of the secondary cause of hypertension, renal Doppler ultrasonography and aldosterone‐to‐renin ratio were normal, thus ruling out primary hyperaldosteronism. About the typical clinical and biochemical presentation, a clinical diagnosis of Liddle syndrome was highly likely. Genetic tests were not performed owing to financial constraints. However, treatment with amiloride brought about remarkable improvement in the control of hypertension and normalization of potassium levels. Conclusion: Liddle’s syndrome should be suspected in cases where there are young individuals who have severe hypertension, hypokalaemia, and an aldosterone‐to‐renin ratio that is normal or low. The diagnosis must be made promptly because delay may lead to complications. In instances where molecular testing is impractical, treatment with ENaC inhibition using amiloride is diagnostic and potentially life‐saving.Keywords
This publication has 20 references indexed in Scilit:
- A Missense Mutation in the Extracellular Domain of αENaC Causes Liddle SyndromeJournal of the American Society of Nephrology, 2017
- The Hypertension Pandemic: An Evolutionary PerspectivePhysiology, 2017
- Liddle syndrome: clinical and genetic profilesThe Journal of Clinical Hypertension, 2016
- Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptomsJournal of Diabetes & Metabolic Disorders, 2016
- Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese PopulationThe Journal of Clinical Hypertension, 2015
- A Controlled Trial of Renal Denervation for Resistant HypertensionNew England Journal of Medicine, 2014
- Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domainBiochemical Journal, 2008
- The PY Motif of ENaC, Mutated in Liddle Syndrome, Regulates Channel Internalization, Sorting and Mobilization from Subapical PoolTraffic, 2007
- Liddle’s Syndrome: Prospective Genetic Screening and Suppressed Aldosterone Secretion in an Extended Kindred*The Journal of Clinical Endocrinology & Metabolism, 1997
- Effects of Amiloride on Arterial Pressure and Renal FunctionThe Journal of Clinical Pharmacology, 1980